Besides BL, c-Myc overexpression drives cell proliferation of a variety of solid and hematological cancers, including Diffuse Large B-Cell Lymphoma (DLBL) and Primary Effusion Lymphoma (PEL), although its translocations/mutations do not frequently occur in most of these cancers [3,4]. The gene discussed is MYC; the disease is Burkitt lymphoma.